Oxymetholone (Anadrol): Potent Oral Anabolic for Mass Research
Oxymetholone, known as Anadrol, is one of the most potent oral anabolic steroids for mass gain. Explore its dramatic anabolic effects, mechanisms, and research applications.
Oxymetholone (commonly known as Anadrol) is a synthetic oral anabolic-androgenic steroid (AAS) derived from dihydrotestosterone (DHT). It is widely regarded as one of the most potent oral anabolic compounds for rapid mass and strength gains. Despite being DHT-derived, oxymetholone produces significant estrogenic-like effects through a unique mechanism, making its pharmacological profile distinct from other DHT derivatives.
Chemical Structure
Oxymetholone is a 17-alpha-alkylated DHT derivative with key modifications:
- DHT base: Unlike most DHT derivatives, oxymetholone produces estrogenic-like effects (see mechanism below) - 17-alpha alkylation: Enables oral bioavailability - 2-hydroxymethylene group: Unique modification responsible for its distinct profile - A-ring modification: Alters the compound's interaction with estrogen pathways
Pharmacokinetics
- Route: Oral (tablet) - Half-life: Approximately 8-9 hours - Bioavailability: High due to 17-alpha alkylation - Metabolism: Hepatic - Duration: Requires 1-2x daily dosing in research protocols
Mechanism of Action
1. Androgen Receptor Binding: Binds androgen receptors — anabolic effects 2. Progestogenic Activity: May have progesterone receptor activity 3. Estrogenic Effects (Unique for DHT-Derived): Despite being DHT-derived (non-aromatizing), oxymetholone produces estrogenic-like effects: - Does NOT aromatize to estrogen - May directly activate estrogen receptors - Or progestogenic activity may produce estrogen-like effects 4. Erythropoiesis: Potent stimulator of red blood cell production 5. Water Retention: Significant water retention (estrogenic-like)
The estrogenic-like effects without aromatization make oxymetholone pharmacologically unique.
Anabolic-to-Androgenic Ratio
| Compound | Anabolic Rating | Androgenic Rating | |---|---|---| | Testosterone | 100 | 100 | | Oxymetholone | ~320 | ~45 |
Research Applications
1. Mass and Strength Research Oxymetholone is one of the most researched compounds for rapid mass gain: - Dramatic, rapid body weight increases - Significant strength improvements - Enhanced protein synthesis - Often produces fastest mass gains among oral AAS
2. Erythropoiesis Research Oxymetholone is uniquely potent at stimulating red blood cell production: - Erythropoietin stimulation - Significant hemoglobin and hematocrit increases - Research in anemia treatment models - Used clinically for anemia in some contexts
3. Wasting/Catabolic Conditions - Muscle preservation in severe catabolic states - Weight restoration in severe wasting - Research in HIV/AIDS-associated wasting - Historical use in osteoporosis research
4. Body Composition Research - Rapid mass gain (including water weight) - Strength enhancement - Research in body composition optimization
Comparison to Other Oral AAS
| Property | Oxymetholone | Methandienone | Oxandrolone | |---|---|---|---| | Potency | Very high | High | Moderate | | Mass gain | Rapid, significant | Rapid, significant | Moderate, dry | | Water retention | Significant | Moderate | None | | Estrogenic | Yes (unique for DHT-derivative) | Yes (aromatizes) | No | | Erythropoiesis | Potent | Moderate | Minimal | | Hepatotoxicity | Significant | Moderate | Low-moderate | | Research cycle | 4-6 weeks | 4-6 weeks | 6-12 weeks |
Standard Research Protocols
- Dose: 25-50mg daily (divided 1-2x daily) - Route: Oral - Duration: 4-6 week cycles (short due to hepatotoxicity) - Monitoring: Liver function (AST/ALT/GGT), lipid panel, blood pressure, hematocrit, hormone panels
Safety Considerations in Research
Hepatotoxicity (Significant): As a 17-alpha-alkylated compound, oxymetholone carries significant hepatotoxicity risk: - Liver enzyme elevations common - Among the more hepatotoxic oral AAS - Cholestasis risk at higher doses - Research protocols require regular liver function monitoring - Peliosis hepatis (rare but documented) risk
Estrogenic Effects: Despite being DHT-derived, oxymetholone produces estrogenic-like effects: - Significant water retention - Potential gynecomastia risk - Blood pressure elevation from water retention - Research protocols monitor these effects
Cardiovascular: - Blood pressure elevation (from water retention) - Adverse lipid changes - Significant cardiovascular strain in research - Research protocols monitor cardiovascular markers closely
Hematocrit: The potent erythropoietic effect requires monitoring: - Hematocrit can increase significantly - Risk of polycythemia (excessive RBCs) - Blood viscosity concerns - Research protocols monitor CBC regularly
Quality Standards for Research
Research-grade oxymetholone should be sourced from suppliers providing: - HPLC purity verification (≥98%) - Certificate of Analysis with batch-specific data - Accurate dosing per tablet (50mg) - Pharmaceutical-grade tablet manufacturing - Proper storage and handling documentation
Storage and Handling
Store at controlled room temperature (20-25°C), protected from light and moisture. Handle with standard laboratory safety protocols.
*This article is for research and informational purposes only. Oxymetholone (Anadrol) is sold for laboratory research purposes only and is not intended for human consumption. Not evaluated by the FDA.*